November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

  • Evidence shows role inflammatory response plays in OA

    Evidence shows role inflammatory response plays in OA

    New research shows that inflammatory pathways may play a role in osteoarthritis development and progression. The new findings offer the first hope of effective treatment for what is by far the most common rheumatic disease.

  • Link between the gut microbiome and lung disease gets researchers’ attention

    Link between the gut microbiome and lung disease gets researchers’ attention

    The interaction between the gut microbiome and autoimmune arthritis-related lung disease will be examined in an ACR symposium on Sunday afternoon.

  • Finding fibrosis fundamentals could improve treatment in many areas

    Finding fibrosis fundamentals could improve treatment in many areas

    Harry Dietz, MD, will discuss the strategies his lab used to explore and to characterize the mechanisms of fibrosis that underlie diseases in the liver, lung, heart, and other organs during an ACR symposium on Sunday morning.

  • EULAR leaders lay out ‘transformative’ vision for RA management

    EULAR leaders lay out ‘transformative’ vision for RA management

    This year’s EULAR session will examine new approaches to therapeutic advances, strategies of care, practical management pathways, application of treatment guidelines, and imaging.

  • Affiliate Society Council takes on emerging issues in state policy

    Affiliate Society Council takes on emerging issues in state policy

    The Affiliate Society Council (ASC) is a vital part of the ACR’s advocacy framework. It brings together rheumatology providers from 42 member states in order to share lessons learned, work through legislative and regulatory issues at the state level, and brainstorm solutions.

  • Rheumatologists can take the lead in orbital inflammatory disease

    Rheumatologists can take the lead in orbital inflammatory disease

    Inflammation of the orbit may be an old problem, but it’s one that rheumatologists are starting to notice. The eye socket is a limited space encompassing inflammatory diseases that can be best treated by a rheumatologist.

  • New project connects rheumatologists to volunteer opportunities to care for underserved populations

    New project connects rheumatologists to volunteer opportunities to care for underserved populations

    The Volunteers to Expand Rheumatology Access (VERA) initiative works to establish a clearinghouse of volunteer opportunities to provide care for underserved rheumatology patients.

  • Build your network through RheumConnect

    Build your network through RheumConnect

    This year, the ACR is hosting RheumConnect—a place for you to meet new mentors and expand your professional network, meet up with like-minded colleagues, put together a group to discuss your next great idea, or catch up with your long-lost colleagues from fellowship.

  • 2018 MACRA final rule: What’s at risk?

    2018 MACRA final rule: What’s at risk?

    The ACR’s Rheumatology Informatics System for Effectiveness (RISE) registry established a high bar of success in 2017, the first reporting year of MIPS. One hundred percent of all users who completed a full submission met or exceeded the exceptional performance threshold for the 2017 reporting period, and 25% received a perfect score.

  • RISE Prospective & Current User Meeting

    RISE Prospective & Current User Meeting

    This session will allow prospective users to see how their practice can benefit from RISE and hear experiences and best practices from current users.